velcade
Showing 1 - 25 of 54
Multiple Myeloma Trial in Worldwide (Daratumumab, velcade, Lenalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +3 more
-
Melbourne, Australia
- +12 more
Aug 25, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Boston (Lenalidomide, Velcade)
Active, not recruiting
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Lenalidomide
- Velcade
-
Boston, Massachusetts
- +1 more
Jun 22, 2021
Multiple Myeloma Trial in Torino (Velcade, Melphalan, Prednisone)
Recruiting
- Multiple Myeloma
- Velcade
- +5 more
-
Torino, TO, ItalyDipartimento di Biotecnologie Molecolari e Scienze per la Salute
May 25, 2022
Multiple Myeloma Trial in France, Spain, United States (Daratumumab, Velcade, Pomalidomide)
Active, not recruiting
- Multiple Myeloma
- Daratumumab
- +11 more
-
Duarte, California
- +21 more
Jan 17, 2023
Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)
Active, not recruiting
- Myeloma
- Melphalan
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Dec 1, 2021
Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)
Active, not recruiting
- Multiple Myeloma
- Velcade
- +7 more
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences
Sep 7, 2021
Nasopharyngeal Carcinoma Trial in Hong Kong, Singapore (Velcade)
Withdrawn
- Nasopharyngeal Carcinoma
- Velcade
-
Hong Kong, China
- +2 more
May 14, 2020
Multiple Myeloma Trial in New York (Velcade, Cyclophosphamide, Chloroquine)
Terminated
- Multiple Myeloma
- Velcade
- +2 more
-
New York, New YorkNYU Cancer Institute
Feb 10, 2020
Non-Hodgkins Lymphoma Trial in United States (Velcade, Temsirolimus)
Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Kansas City (Velcade, Methotrexate, Methotrexate / Hydrocortisone
Terminated
- Acute Lymphoblastic Leukemia
- Lymphoblastic Lymphoma
- Velcade
- +6 more
-
Kansas City, MissouriChildren's Mercy Hospital
Jul 23, 2019
Peripheral T-cell Lymphoma Trial in Belgium, France (Velcade, Doxorubicin, Prednisone)
Completed
- Peripheral T-cell Lymphoma
- Velcade
- +5 more
-
Yvoir, Belgium
- +4 more
Aug 21, 2018
Leukemia, Acute Lymphocytic Leukemia Trial in Stanford (Velcade)
Withdrawn
- Leukemia
- Acute Lymphocytic Leukemia
- Velcade
-
Stanford, CaliforniaStanford University School of Medicine
May 16, 2018
Non-Hodgkin's Lymphoma, Mantle Cell Lymphoma Trial in Columbus (Velcade, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- Mantle Cell Lymphoma
- Velcade
- Rituximab
-
Columbus, OhioOhio State University Medical Center
Mar 7, 2018
Multiple Myeloma Trial in United States (Revlimid, Velcade, dexamethasone)
Multiple Myeloma Trial in Salt Lake City (Velcade)
Terminated
- Multiple Myeloma
- Velcade
-
Salt Lake City, UtahHuntsman Cancer Institute
Aug 4, 2017
Multiple Myeloma Trial in Durham (Velcade, Cyclophosphamide, Revlimid)
Terminated
- Multiple Myeloma
- Velcade
- +2 more
-
Durham, North CarolinaDuke University Medical Center
Apr 26, 2017
Leukemia, MDS, Myelodysplastic/Myeloproliferative Tumors Trial in Columbus (Vidaza, Velcade)
Completed
- Leukemia
- +2 more
- Vidaza
- Velcade
-
Columbus, OhioOhio State University Medical Center
Aug 21, 2017
Multiple Myeloma Trial in Little Rock (Velcade, Thalidomide)
Completed
- Multiple Myeloma
- Velcade
- Thalidomide
-
Little Rock, ArkansasUniversity of Arkansas for Medical Sciences/MIRT
Sep 13, 2017
Multiple Myeloma Trial in Shanghai (velcade)
Terminated
- Multiple Myeloma
- velcade
-
Shanghai, ChinaRui Jin Hospital, Shanghai JiaoTong University School of Medicin
Sep 6, 2016
Multiple Myeloma Trial in Spain (Melphalan, Prednisone, Velcade)
Completed
- Multiple Myeloma
- Melphalan
- +4 more
-
Palma de Mallorca, Baleares, Spain
- +62 more
Jan 16, 2017
Lymphoma, Non-Hodgkin Trial in United States (Fludarabine, Velcade, Rituximab)
Multiple Myeloma Trial in Stanford (velcade, Pralatrexate)
Completed
- Multiple Myeloma
- velcade
- Pralatrexate
-
Stanford, CaliforniaStanford University School of Medicine
Jul 5, 2016